SCHEMBL6547544

SCHEMBL6547544

Fc1cccc(N=C(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.50
ESR2 Q92731 6/20 0.50
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
KMT2A Q03164 1/20 0.43
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
HPGD P15428 1/20 0.42
IDO1 P14902 2/20 0.42
PKM P14618 1/20 0.41
PARP1 P09874 1/20 0.41
AGTR1 P30556 1/20 0.40
OPRK1 P41145 1/20 0.40
CRHR1 P34998 1/20 0.40
CTSL P07711 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4450591 0.79 ESR2 (0.74) ESR1ESR2KMT2A
SCHEMBL5249715 0.78 ESR2 (0.62) ESR1ESR2KMT2ARAB9A
SCHEMBL3847320 0.78 ESR1 (0.43) ESR1ESR2KMT2ARAB9ANPC1
SCHEMBL16229876 0.78 MGLL (0.48) ESR1ESR2
SCHEMBL13171829 0.78 ESR2 (0.68) ESR1ESR2KMT2A
SCHEMBL4668221 0.77 ESR1 (0.50) ESR1ESR2KMT2AHPGDIDO1
SCHEMBL12336908 0.77 ESR2 (0.78) ESR1ESR2KMT2A
Ammonia Solution, Strong SCHEMBL4910431 0.76 ESR1 (0.48) ESR1ESR2KMT2AHPGDIDO1
SCHEMBL6028666 0.74 CES2 (0.46) CES2CES1KMT2ARAB9ANPC1
SCHEMBL6028679 0.74 CES2 (0.46) CES2CES1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107739338-A Formamide and urea derivative as capsaicin analog receptors ligand 美迪福伦DBT有限公司 2018-02-27 CN disclosed
EP-1100774-B1 IMPROVED ARYLAMINE SYNTHESIS MASSACHUSETTS INST TECHNOLOGY (US) 2004-01-21 EP disclosed
US-6323366-B1 ACTIVATED ARYL GROUP AND AN IMINE GROUP ARE COMBINED, IN THE PRESENCE OF A TRANSITION METAL CATALYST FOR FORMATION OF A CARBON-NITROGEN BOND BETWEEN THE ACTIVATED CARBON OF THE ARENE AND IMINE NITROGEN; CONVERTING TO ARYLAMINE MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2001-11-27 US disclosed
EP-1100774-A1 IMPROVED ARYLAMINE SYNTHESIS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2001-05-23 EP disclosed
WO-2000005199-A1 IMPROVED ARYLAMINE SYNTHESIS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2000-02-03 WO disclosed